Background: Multiple Sclerosis is a heterogeneous disorders involving in early stage gait and balance. Together with immunomodulating therapies, rehabilitation had a crucial role in improving motor tasks and quality of life. Between the emerging techniques, Focal Vibrations (FV) could play a role, but they have been used in MS only to reduce muscle tone and fatigue alone or together with botulinum toxin.
Objective: To assess whether FV is effective on walking impairment in a cohort of MS patients.
Methods: We performed a single-centre randomized, double-blind, sham-controlled study to investigate efficacy of FV vs sham vibration in 20 RR MS patients. Ten patients received treatment with the active device and ten patients sham treatment. Demographical, clinical and gait instrumental data analysis have been collected for each patient at baseline (T0), after treatment (T1) and after three weeks of wash out (T2).
Results: Both groups were clinically and demographically comparable. Treated patients showed significant improvements during the first right step (FRS) (p = 0.007), average stride lenght (ASL) (p = 0.012), double support right (DSRT) (p = 0.016) and left (DSLT) (p = 0.003) time. Non-treated patients didn’t show any significance for any dynamic variables. Moreover, on posturographic measurements we registered only a trend towards significance in swing area with eyes open (SAEO) (p = 0.087). We also found in treated group significant improvements in FRT (p = 0.018); BBS (p = 0.037) and FSS scales (p = 0.038) between T1 and T0. Lastly, we found a significant inverse correlation in the treated group between disease duration and percentage of improvement for DSLT (r = – 0.775; p = 0.014) in T1 vs T0 and percentage of improvement of FSS, with an inverse correlation with both disease duration (r = – 0.775; p = 0.014) and AGE (r = – 0.733, p = 0.025) in T1 vs T0
Conclusion: Our results suggest a beneficial effect of FV on walking impairment in MS patients suffering from spasticity and/or postural instability, which partially lasted until follow up.
AlfonsiE., PaoneP., TassorelliC., De IccoR., MogliaA., AlvisiE., & SandriniG. (2015). Acute effects of high-frequency microfocal vibratory stimulation on the H reflex of the soleus muscle. A double-blind study in healthy subjects. Functional Neurology, 30(4), 269–274.
2.
Berg.K., Wood-DauphineeS., & WilliamsJ.I. (1995). The Balance Scale: Reliability assessment with elderly residents and patients with an acute stroke. Scandiavinan Journal of Rehabilitation Medicine, 27, 27–36.
3.
BohannonR.W., & SmithM.B. (1987). Interrater reliability of a modified Ashworth scale of muscle spasticity. Physical Therapy, 67(2), 206–207.
4.
CorradiniM.L., FiorettiS., LeoT., & PipernoR. (1997). Early recognition of postural disorders in multiple sclerosis through movement analysis: A modeling study. IEEE Transaction on Biomedical Engineering, 44, 1029–1038.
5.
DibbleL.E., Lopez-LennonC., LakeW., HoffmeisterC., & GappmaierE. (2013). Utility of disease specifics measures and clinical balance tests in prediction of falls in persons with multiple sclerosis. Journal of Neurologic Physical Therapy, 37(3), 99–104.
6.
DuncanP.W., WeinerD.K., ChandlerJ., & StudenskiS. (1990). Functional reach: A new clinical measure of balance. M-M. Journal of Gerontology, 45, 197–.
7.
FeinsteinA., FreemanJ., & LoA.C. (2015). Treatment of progressive multiple sclerosis: What works, what does not, and what is needed. Lancet Neurology, 14(2), 194–207. doi: 10.1016/S1474-4422(14)70231-5.
8.
ForsbergA., AndreassonM., & NilsagardY.E. (2013). Validity of the dynamic gait index in people with multiple sclerosis. Physical Therapy Journal, 93(10), 1369–1376.
9.
FritzN.E., JiangA., KellerJ., & ZackowskiK.M. (2015). Utility of the six-spot step test as a measure of walking performance in ambulatory individuals with multiple sclerosis. Archives of Physical Medicine and Rehabilitation, 97(4), 507–512. doi: 10.1016/j.apmr.2015.10.100.
10.
GijbelsD., DalgasU., & RombergA. (2012). Which walking capacity test to use in Multiple Sclerosis? A multicentre study providing the basis for a core set. Multiple Sclerosis, 18, 364–371.
11.
HobartJ.C., RiaziA., LampingD.L., FitzpatrickR., & ThompsonAJ. (2003). Measuring the impact of MS on walking ability: The 12-Item MS Walking Scale (MSWS-12). Neurology, 14, 31–36.
12.
KanteleS., KarinkantaS., & SievänenH. (2015). Effects of long-term whole-body vibration training on mobility in patients with multiple sclerosis: A meta-analysis of randomized controlled trials. Journal of the Neurological Sciences, 15, 31–37.
KruppL.B., La RoccaN.G., Muir-NashJ., & SteinbergAD. (1989). The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Archives of Neurology, 46(10), 1121–1123.
15.
KurtzkeJ.F. (1983). Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS. Neurology, 33(11), 1444–1452.
16.
LarsonR.D., LarsonD.J., BaumgartnerT.B., & WhiteL.J. (2013). Repeatability of the timed 25–foot walk test for individuals with multiple sclerosis. Clinical Rehabilitation, 27(8), 719–723.
17.
MartinC.L., PhillipsB.A., KilpatrickT.J., ButzkuevenH., TubridyN., McDonaldE., & GaleaM.P. (2006). Gait and balance impairment in early multiple sclerosis in the absence of clinical disability. Multiple Sclerosis, 12, 620–628.
18.
MotlR.W., SandroffB.M., SuhY., & SosnoffJ.J. (2012). Energy cost of walking and its association with gait parameters, daily activity, and fatigue in persons with mild multiple sclerosis. Neurorehabilitation and Neural Repair, 26(8), 1015–1021.
19.
MurilloN., Valls-SoleJ., VidalJ., OpissoE., MedinaJ., & KumruH. (2014). Focal Vibration in Neurorehabilitation. European Journal of Physical and Rehabilitation Medicine, 50(2), 231–242.
20.
NeckingL.E., LundströmR., DahlinL.B., LundborgG., ThornellL.E., & FridènJ (1996). Tissue displacement is a causative factor in vibration-induced muscle injury. Journal of Hand Surgery British, 21(6), 753–757.
21.
PaltamaaJ., SjögrenT., PeuralaS.H., & HeinonenA. (2012). Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials. Journal of Rehabilitation Medicine,, 44(10), 811–823.
22.
PaoloniM., GiovannelliM., MangoneM., LeonardiL., TaverneseE., Di PangrazioE., … & PozzilliC. (2013). Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial. Clinical Rehabilitation, 27(9), 803–812.
23.
PolmanC.H., ReingoldS.C., BanwellB., ClanetM., CohenJ.A., FilippiM., & WolinskyJ.S. (2011). Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology, 69(2), 292–302.
StraudiS., FanciullacciC., MartinuzziC., PavarelliC., RossiB., ChisariC., & BasagliaN. (2016). The effects of robot-assisted gait training in progressive multiple sclerosis: A randomized controlled trial. Multiple Sclerosis, 22(3), 373–384.
26.
SwinnenE., BeckwéeD., PinteD., MeeusenR., BaeyensJ.P., & KerckhofsE. (2012). Treadmill training in multiple sclerosis: Can body weight support or robot assistance provide added value? A systematic review. Multiple SclerosisInt.;240274.
27.
ValkovicP., KrafczykS., & BotzelK. (2006). Postural reactions to soleus muscle vibration in Parkinson’s disease: Scaling deteriorates as disease progresses. Lett, 401, 92–96.
28.
ValkovicP., KrafczykS., SalingM., BenetinJ., & BotzelK. (2006). Postural reactions to neck vibration in Parkinson’s disease. Movement Disorders Journal, 21, 59–65.
29.
VolpeD., GiantinM.G., & FasanoA. (2014). A wearable proprioceptive stabilizer (equistasi®) for rehabilitation of postural instability in Parkinson’s disease: A phase II randomized double-blind, double-dummy, controlled study. PloS One, 17, 9(11), e112065..
